Concord Healthcare Grp Co Ltd (2453.HK)
HKD 13.74
(-2.69%)
HKD 13.74
(-2.69%)
| Breakdown | 2023 | 2022 | 2021 | 2020 | 2019 |
|---|---|---|---|---|---|
| Operating Cash Flow | 79.62 Million | -267.82 Million | 45.87 Million | -51.84 Million | -401.82 Million |
| Net Income | -412.26 Million | -629.58 Million | -984.16 Million | -655.4 Million | -318.51 Million |
| Depreciation & Amortization | 167.96 Million | 172.16 Million | 137.4 Million | 94.3 Million | 56.48 Million |
| Deferred income taxes | - | - | - | - | - |
| Stock-based compensation | - | - | - | - | - |
| Change in working capital | 479.24 Million | 185.55 Million | 520.5 Million | 257.42 Million | -250.28 Million |
| Other non-cash items | -126.8 Million | 341.02 Million | 672.17 Million | 461.34 Million | 221.27 Million |
| Investing Cash Flow | -203.04 Million | -117.48 Million | -1.14 Billion | -960.19 Million | -391.82 Million |
| Investments in PPE | -203.04 Million | -98.71 Million | -630.11 Million | -863.58 Million | -452.84 Million |
| Acquisitions | - | 773.31 Thousand | -130.51 Million | 1.67 Million | 1.18 Million |
| Investment purchases | - | -19.53 Million | -398.68 Million | -98.28 Million | -258.53 Thousand |
| Sales/Maturities of investments | - | - | 15.9 Million | - | - |
| Other Investing Activities | -4.41 Million | - | - | - | 60.09 Million |
| Financing Cash Flow | 61.62 Million | 374.15 Million | 749.53 Million | 1.42 Billion | 687.66 Million |
| Debt repayment | -21.77 Million | -175.37 Million | -771.75 Million | -1.58 Billion | -725.44 Million |
| Dividends payments | - | - | - | - | - |
| Common Stock Repurchased | - | - | - | - | - |
| Common Stock Issuance | 331.49 Million | -19.75 Million | -6.11 Million | 700 Million | - |
| Other Financing Activities | -231.94 Million | 226.11 Million | 5.93 Million | -152.79 Million | -26.43 Million |
| Accounts receivables | 278.97 Million | 9.81 Million | -95.89 Million | -10.21 Million | 598.7 Thousand |
| Accounts payables | -20.76 Million | 51.87 Million | 59.85 Million | 9.32 Million | 4.27 Million |
| Inventory | 49.19 Million | -54.35 Million | 10.79 Million | -20 Million | -2.68 Million |
| Other working capital | 171.82 Million | 178.21 Million | 545.75 Million | 278.33 Million | -252.47 Million |
| Cash at beginning of period | 142.02 Million | 166.46 Million | 503.69 Million | 67.12 Million | 173.11 Million |
| Cash at end of period | 77.7 Million | 142.02 Million | 166.46 Million | 503.69 Million | 67.12 Million |
| Capital Expenditure | -203.04 Million | -98.71 Million | -630.11 Million | -863.58 Million | -452.84 Million |
| Effect of forex changes on cash | - | - | - | - | - |
| Net cash flow / Change in cash | -64.31 Million | -24.44 Million | -337.22 Million | 436.57 Million | -105.99 Million |
| Free Cash Flow | -123.41 Million | -366.54 Million | -584.24 Million | -915.43 Million | -854.67 Million |
| Breakdown | 2024 Q2 | 2024 Q1 | 2023 Q4 | 2023 FY | 2023 Q3 | 2023 Q2 |
|---|---|---|---|---|---|---|
| Operating Cash Flow | - | - | - | - | - | - |
| Net Income | -97.71 Million | -98.55 Million | -98.35 Million | -412.26 Million | -95.89 Million | -219.71 Million |
| Depreciation & Amortization | 39.82 Million | 40.16 Million | 41.55 Million | 167.96 Million | 38.53 Million | 86.48 Million |
| Deferred income taxes | - | - | - | - | - | - |
| Stock-based compensation | - | - | - | - | - | - |
| Change in working capital | -21.97 Million | -22.16 Million | 256.12 Million | 479.24 Million | 249.7 Million | -38.16 Million |
| Other non-cash items | -16.19 Million | -16.33 Million | -16.34 Million | -126.8 Million | -13.96 Million | 48.26 Million |
| Investing Cash Flow | -249.47 Million | -251.62 Million | -97.94 Million | -203.04 Million | -95.49 Million | -5.45 Million |
| Investments in PPE | -90.28 Million | -91.06 Million | -96.2 Million | -203.04 Million | -93.79 Million | -5.45 Million |
| Acquisitions | 10.66 Million | - | - | - | - | - |
| Investment purchases | -332.24 Million | - | - | - | - | - |
| Sales/Maturities of investments | - | - | - | - | - | - |
| Other Investing Activities | -159.19 Million | -160.56 Million | -1.73 Million | - | -1.69 Million | -673.36 Thousand |
| Financing Cash Flow | 383.66 Million | 386.96 Million | -204.23 Million | 61.62 Million | -199.11 Million | 389.86 Million |
| Debt repayment | -356.14 Million | - | -49.45 Million | -21.77 Million | - | -28.16 Million |
| Dividends payments | - | - | - | - | - | - |
| Common Stock Repurchased | - | - | - | - | - | - |
| Common Stock Issuance | 546.36 Million | - | -9.64 Million | 331.49 Million | - | 333.74 Million |
| Other Financing Activities | 383.66 Million | 386.96 Million | -204.23 Million | -231.94 Million | -199.11 Million | 33.62 Million |
| Accounts receivables | 1.91 Million | 1.93 Million | -1.8 Million | 278.97 Million | -1.76 Million | 31.37 Million |
| Accounts payables | 1.75 Million | - | -855.1 Thousand | -20.76 Million | - | -19.44 Million |
| Inventory | 62.85 Thousand | 63.4 Thousand | 1.29 Million | 49.19 Million | 1.25 Million | 47.69 Million |
| Other working capital | -23.94 Million | -24.15 Million | 256.63 Million | 171.82 Million | 250.2 Million | -97.79 Million |
| Cash at beginning of period | 77.7 Million | - | 277.59 Million | 142.02 Million | - | 142.02 Million |
| Cash at end of period | 38.12 Million | 38.45 Million | 77.7 Million | 77.7 Million | -116.22 Million | 277.59 Million |
| Capital Expenditure | -90.28 Million | -91.06 Million | -96.2 Million | -203.04 Million | -93.79 Million | -5.45 Million |
| Effect of forex changes on cash | - | - | - | - | - | - |
| Net cash flow / Change in cash | -39.57 Million | 38.45 Million | -199.88 Million | -64.31 Million | -116.22 Million | 135.56 Million |
| Free Cash Flow | -186.34 Million | -187.95 Million | 86.75 Million | -123.41 Million | 84.57 Million | -241.92 Million |
ADF
ASSF
0RG7
HEAL
WFHG
NATURAL